Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Bates

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
The Oncologist|January 31, 2012
Editor's Note ...Clinical Trial Reports: A New SectionTito Fojo, Susan Bates, Bruce A Chabner
European Journal of Pharmacology|August 1, 2006
The effects of paeonol on the electrophysiological properties of cardiac ventricular myocytesYu-ling Ma, Susan Bates, Alison M Gurney
The Journal of Biological Chemistry|March 6, 2004
Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2Junkang Xu, Yang Liu, Youyun Yang, et al.
Cancer Biology & Therapy|March 19, 2003
The histone deacetylase inhibitor FR901228 (desipeptide) restores expression and function of pseudo-null p53Masaki Kitazono, Susan Bates, Patrick Fok, et al.
Plos One|May 7, 2014
Continuing a cancer treatment despite tumor growth may be valuable: sunitinib in renal cell carcinoma as exampleMauricio Burotto, Julia Wilkerson, Wilfred Stein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
The histone deacetylase inhibitor FK228 preferentially enhances adenovirus transgene expression in malignant cellsMerrill E Goldsmith, Masaki Kitazono, Patrick Fok, et al.
Blood|March 6, 2002
Histone deacetylase inhibitor FR901228 enhances adenovirus infection of hematopoietic cellsMasaki Kitazono, Vemulkonda Koneti Rao, Rob Robey, et al.
Cell Cycle (Georgetown, Tex.)|February 2, 2008
PolyHEMA spheroids are an inadequate model for the drug resistance of the intractable solid tumorsKenneth Steadman, Wilfred D Stein, Thomas Litman, et al.
Oncotarget|September 25, 2020
ATM inhibition overcomes resistance to histone deacetylase inhibitor due to p21 induction and cell cycle arrestLuigi Scotto, Xavier J Serrano, Kelly Zullo, et al.
The Oncologist|June 5, 2015
Phase II Clinical Trial of Ixabepilone in Metastatic Cervical CarcinomaMauricio Burotto, Maureen Edgerly, Marianne Poruchynsky, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
The Oncologist|January 31, 2012
Editor's Note ...Clinical Trial Reports: A New SectionTito Fojo, Susan Bates, Bruce A Chabner
European Journal of Pharmacology|August 1, 2006
The effects of paeonol on the electrophysiological properties of cardiac ventricular myocytesYu-ling Ma, Susan Bates, Alison M Gurney
The Journal of Biological Chemistry|March 6, 2004
Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2Junkang Xu, Yang Liu, Youyun Yang, et al.
Cancer Biology & Therapy|March 19, 2003
The histone deacetylase inhibitor FR901228 (desipeptide) restores expression and function of pseudo-null p53Masaki Kitazono, Susan Bates, Patrick Fok, et al.
Plos One|May 7, 2014
Continuing a cancer treatment despite tumor growth may be valuable: sunitinib in renal cell carcinoma as exampleMauricio Burotto, Julia Wilkerson, Wilfred Stein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
The histone deacetylase inhibitor FK228 preferentially enhances adenovirus transgene expression in malignant cellsMerrill E Goldsmith, Masaki Kitazono, Patrick Fok, et al.
Blood|March 6, 2002
Histone deacetylase inhibitor FR901228 enhances adenovirus infection of hematopoietic cellsMasaki Kitazono, Vemulkonda Koneti Rao, Rob Robey, et al.
Cell Cycle (Georgetown, Tex.)|February 2, 2008
PolyHEMA spheroids are an inadequate model for the drug resistance of the intractable solid tumorsKenneth Steadman, Wilfred D Stein, Thomas Litman, et al.
Oncotarget|September 25, 2020
ATM inhibition overcomes resistance to histone deacetylase inhibitor due to p21 induction and cell cycle arrestLuigi Scotto, Xavier J Serrano, Kelly Zullo, et al.
The Oncologist|June 5, 2015
Phase II Clinical Trial of Ixabepilone in Metastatic Cervical CarcinomaMauricio Burotto, Maureen Edgerly, Marianne Poruchynsky, et al.
Pageof 4